1. Home
  2. MYND vs RFL Comparison

MYND vs RFL Comparison

Compare MYND & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mynd.ai Inc.

MYND

Mynd.ai Inc.

HOLD

Current Price

$0.35

Market Cap

21.4M

Sector

Real Estate

ML Signal

HOLD

Logo Rafael Holdings Inc. Class B

RFL

Rafael Holdings Inc. Class B

HOLD

Current Price

$1.23

Market Cap

63.5M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
MYND
RFL
Founded
1998
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Real Estate
Sector
Real Estate
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
21.4M
63.5M
IPO Year
2017
2017

Fundamental Metrics

Financial Performance
Metric
MYND
RFL
Price
$0.35
$1.23
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
12.1K
68.9K
Earning Date
03-26-2026
03-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
28.28
EPS
N/A
N/A
Revenue
N/A
$917,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
43.96
52 Week Low
$0.29
$1.12
52 Week High
$1.15
$3.19

Technical Indicators

Market Signals
Indicator
MYND
RFL
Relative Strength Index (RSI) 40.57 41.84
Support Level $0.29 $1.15
Resistance Level $0.58 $1.59
Average True Range (ATR) 0.05 0.09
MACD -0.00 -0.01
Stochastic Oscillator 12.50 7.41

Price Performance

Historical Comparison
MYND
RFL

About MYND Mynd.ai Inc.

Mynd.ai Inc is a company that provides a platform for delivering digital content in K-12 classrooms, giving teachers seamless connectivity to inspire young minds. It features agnostic hardware that integrates across technology providers. Its product line includes a wide range of interactive tools and technologies, with its award-winning interactive displays at the forefront. It also offers interactive software apps such as Screen Share, computing modules, and accessories that meet the needs of customers, including K -12 educators, colleges and universities, small businesses and corporations, government agencies, and more. Geographically, it operates in United States and Rest of the world.

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.

Share on Social Networks: